Literature DB >> 11124052

Working toward an adenoviral vector testing standard.

B Hutchins1, N Sajjadi, S Seaver, A Shepherd, S R Bauer, S Simek, K Carson, E Aguilar-Cordova.   

Abstract

Mesh：

Year:  2000        PMID： 11124052     DOI： 10.1006/mthe.2000.0217

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  3 in total

1.  Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth.

Authors:  Susanna Purhonen; Jarmo Palm; Derrick Rossi; Nina Kaskenpää; Iiro Rajantie; Seppo Ylä-Herttuala; Kari Alitalo; Irving L Weissman; Petri Salven
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-28       Impact factor: 11.205

2.  Development of the First World Health Organization Lentiviral Vector Standard: Toward the Production Control and Standardization of Lentivirus-Based Gene Therapy Products.

Authors:  Yuan Zhao; Hannah Stepto; Christian K Schneider
Journal:  Hum Gene Ther Methods       Date:  2017-08       Impact factor: 2.396

Review 3.  Virus-like particles: preparation, immunogenicity and their roles as nanovaccines and drug nanocarriers.

Authors:  Saghi Nooraei; Howra Bahrulolum; Zakieh Sadat Hoseini; Camellia Katalani; Abbas Hajizade; Andrew J Easton; Gholamreza Ahmadian
Journal:  J Nanobiotechnology       Date:  2021-02-25       Impact factor: 10.435
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.